Novel Drug Delivery Platform
Milk Derived Exosomes for Non-Immunogenic Delivery of Peptide Drugs directly to injured tissues
About Us
The Tiny Cargo Company
The Tiny Cargo Company has innovated a novel drug delivery system based on non-immunogenic bovine milk derived exosomes for protected oral or IV based delivery of potent therapeutics
Current Approaches
Tiny Cargo currently has aims in treating Ischemic Heart Disease, Gastrointestinal Radiation Disease, Glioblastoma Multiforme, and numerous other pathologies. Treatment for every disease is within reach with our drug delivery platform
Our Advantages
We utilize non-immunogenic milk derived exosomes to deliver potent therapeutics, with limited first pass metabolism and a patented, highly efficient method of loading, to enhance upon current approaches such as nanoparticles and liposomal drug carriers
Subscribe
Our Services
Targeted Delivery
Our drug delivery vesicles are naturally programmed to hone to tissues of interest
Platform Technology
Our loading technology is innately capable of being applied to all current peptide therapeutics, including mRNA and miRNA products
Oral Administration
Our exosomes are capable of bypassing the gut-blood barrier in moments, and also of bypassing other critical barriers such as the blood-brain barrier, allowing for treatment of neurological pathologies
Contact Us
Contact Us
Please contact us with any questions about our business
Feel free to contact us- Spencermarsh@tinycargo.com
The Tiny Cargo Company
Copyright © 2022 Tiny Cargo - All Rights Reserved.
Powered by GoDaddy
This website uses cookies.
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.